TY  - JOUR

T1  - CONFIRM: A double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: Study protocol for a randomised controlled trial

JO  - Trials

UR  - http://eprints.whiterose.ac.uk/131013/

PY  - 2018/04/18

AU  - Fennell DA

AU  - Kirkpatrick E

AU  - Cozens K

AU  - Nye M

AU  - Lester J

AU  - Hanna G

AU  - Steele N

AU  - Szlosarek P

AU  - Danson S

AU  - Lord J

AU  - Ottensmeier C et al

ED  - 

DO  - DOI: 10.1186/s13063-018-2602-y

VL  - 19

IS  - 1

Y2  - 2024/09/19

ER  -